Science

Everything You Need To Know About Aspirin: Can It Really Beat Up Cancer And Extend Your Life?

By Sai , Dec 03, 2016 07:46 AM EST
Close

A new study has recently claimed that older Americans who take a low dose of aspirin every day with drastically cut their risk of contracting heart disease or cancer. As a matter of fact, apart from this study finding, researchers have also found out that regular bouts of the medication could extend lifespan and save the lives of hundreds of thousands of patients currently at risk of disease. Moreover, study highly emphasizes that such a boost in general health among elderly people could save US taxpayers $692 billion.

How Did The Study Arrive At That Conclusion?

In one of his statements reported by Daily Mail, study lead author David B. Agus, a USC professor of medicine and engineering has revealed that although he health benefits of aspirin are well established, few people take it. Agus claimed that their study has shown multiple health benefits and a reduction in healthcare spending from this simple, low-cost measure that should be considered a standard part of care for the appropriate patient.

Furthermore, Mirror has revealed that the substantial findings also show the compelling evidence which proves that cancer patients can easily improve their odds of surviving the disease by as much as a fifth by simply popping the painkiller. The common drug is perceived to help block off certain cancer molecules which allows the tumors to dodge treatment.

Meanwhile, experts claim that Aspirin also has the ability of helping those patients who are at risk of heart disease because it thins the blood and prevents clotting. It was found that for the team's study, USC researchers have utilized representative data from several national surveys. In order for them to assess the long-term benefits of aspirin, the USC researchers were found to have used the university's Future Elderly Model, which projects the health of older Americans and their trajectory in aging.

Ultimately, study co-author Dana Goldman, director of the Schaeffer Center for Health Policy and Economics and distinguished professor of public policy, pharmacy, and economics has further added that the irony of their findings is that aspirin may be too cheap, contrary to what other people think that it can be costly. It was found that only 40 percent of Americans are taking aspirin when they should, and providers have little incentive to push that number up, despite the obvious health benefits and healthcare savings

Related Articles

© 2019 ITECHPOST, All rights reserved. Do not reproduce without permission.
Real Time Analytics